Q4 2025 Bioceres Crop Solutions Corp Earnings Call Transcript
Key Points
- Bioceres Crop Solutions Corp (BIOX) reported strong international sales growth, with adjuvant sales in Brazil almost doubling and bio-protection products in the US growing by nearly 40%.
- The company achieved a solid operating cash flow of $29.9 million in the fourth quarter, up 28% year-over-year, and $53 million for the full fiscal year, a 27% increase versus last year.
- Bioceres Crop Solutions Corp (BIOX) has implemented cost control measures, achieving $5.7 million in operating expense savings and targeting further savings of 10% to 12% in operating expenses.
- The company has reduced its rate of incremental CapEx and R&D investments by 50%, which is expected to lower it from nearly 6% of sales to between 2.5% and 3% for fiscal years '26 and '27.
- Bioceres Crop Solutions Corp (BIOX) is focusing on scaling up its biological initiatives and has achieved registration of RinoTec in the US and Brazil, which is expected to contribute to future growth.
- Bioceres Crop Solutions Corp (BIOX) reported a 40% decline in fourth-quarter revenues compared to the same period last year, primarily due to a winding down of its seed business and weaker demand for crop inputs in Argentina.
- The company's gross profit for the fourth quarter was $25.4 million, a 47% reduction compared to the same quarter last year, with significant declines in the Crop Nutrition and Seeds segments.
- Adjusted EBITDA for the quarter was negative $4.5 million, down from $19.9 million the year before, largely due to a $22.7 million gross profit reduction.
- Bioceres Crop Solutions Corp (BIOX) faced nonrecurring impairments of $5 million in the quarter, linked to bad debts in Bolivia and the HB4 rollback.
- The company's net debt to adjusted EBITDA ratio increased to 7.8x due to a stable net debt but substantially lower adjusted EBITDA.
Welcome all to the Bioceres Crop Solutions fiscal fourth-quarter and full year 2025 financial results. My name is Drew, and I'll be the operator on the call today. (Operator Instructions)
With that, it's now my pleasure to hand over to Paula Savanti from Investor Relations to begin. Please go ahead when you're ready.
Thank you. Good morning, everyone, and welcome to Bioceres Crop Solutions fiscal fourth-quarter and full year 2025 earnings conference call. Our prepared remarks today will be led by our Chief Executive Officer, Federico Trucco; and myself as Head of Investor Relations. Both of us will be available for the Q&A session following the presentation.
During this call, we will make forward-looking statements. These statements are based on current expectations and assumptions that are subject to various risks and uncertainties. I refer you to the forward-looking statements section of the earnings release and presentation as well as the recent filings with the SEC
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
